These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Shariat SF; Karakiewicz PI; Suardi N; Kattan MW Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454 [TBL] [Abstract][Full Text] [Related]
5. A catalog of prostate cancer nomograms. Ross PL; Scardino PT; Kattan MW J Urol; 2001 May; 165(5):1562-8. PubMed ID: 11342918 [TBL] [Abstract][Full Text] [Related]
6. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling. Nguyen CT; Kattan MW Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545 [TBL] [Abstract][Full Text] [Related]
7. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer. Nguyen CT; Zelefsky MJ; Kattan MW Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540 [TBL] [Abstract][Full Text] [Related]
8. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709 [TBL] [Abstract][Full Text] [Related]
9. Predictive tools for prostate cancer staging, treatment response and outcomes. Green DA; Osterberg EC; Xylinas E; Rink M; Karakiewicz PI; Scherr DS; Shariat SF Arch Esp Urol; 2012 Nov; 65(9):787-807. PubMed ID: 23154603 [TBL] [Abstract][Full Text] [Related]
10. Predictive models before and after radical prostatectomy. Capitanio U; Briganti A; Gallina A; Suardi N; Karakiewicz PI; Montorsi F; Scattoni V Prostate; 2010 Sep; 70(12):1371-8. PubMed ID: 20623635 [TBL] [Abstract][Full Text] [Related]
11. Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer. Hammerer PG; Kattan MW; Mottet N; Prayer-Galetti T BJU Int; 2006 Jul; 98(1):11-9. PubMed ID: 16566811 [TBL] [Abstract][Full Text] [Related]
12. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. Chun FK; Haese A; Ahyai SA; Walz J; Suardi N; Capitanio U; Graefen M; Erbersdobler A; Huland H; Karakiewicz PI Cancer; 2008 Aug; 113(4):701-9. PubMed ID: 18553365 [TBL] [Abstract][Full Text] [Related]
13. Predicting life expectancy in prostate cancer patients. Jeldres C; Latouff JB; Saad F Curr Opin Support Palliat Care; 2009 Sep; 3(3):166-9. PubMed ID: 19553817 [TBL] [Abstract][Full Text] [Related]
15. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer. Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T; J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221 [TBL] [Abstract][Full Text] [Related]
17. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy. Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280 [TBL] [Abstract][Full Text] [Related]
18. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database. Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946 [TBL] [Abstract][Full Text] [Related]
19. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925 [TBL] [Abstract][Full Text] [Related]
20. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists. Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]